Diadema Partners LP Amicus Therapeutics, Inc. Transaction History
Diadema Partners LP
- $328 Billion
- Q2 2025
A detailed history of Diadema Partners LP transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Diadema Partners LP holds 131,400 shares of FOLD stock, worth $1.18 Million. This represents 0.23% of its overall portfolio holdings.
Number of Shares
131,400Holding current value
$1.18 Million% of portfolio
0.23%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding FOLD
# of Institutions
308Shares Held
332MCall Options Held
396KPut Options Held
249K-
Vanguard Group Inc Valley Forge, PA29.4MShares$264 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA29.1MShares$262 Million0.03% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$219 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY18MShares$162 Million1.88% of portfolio
-
William Blair Investment Management, LLC Chicago, IL14.6MShares$132 Million0.24% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.52B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...